Insider · CIK 0001554194

Talbot George Harrison

Reports to the SEC for 3 companies · MORRISTOWN, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001554194

Forms 4 and 5

Insider transactions

28 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-07-29	Nabriva Therapeutics plcA Award	Director	AAward	+17.5K sh	—	—	65,140
2020-07-29	Nabriva Therapeutics plcStock OptionsA Award	Director	AAward	+35K sh	—	—	35,000
2019-07-31	Nabriva Therapeutics plcStock OptionA Award	Director	AAward	+35K sh	—	—	35,000
2018-07-31	Nabriva Therapeutics plcP Purchase	Director	PPurchase	+14.5K sh	$2.75	+$39.9K	47,640
2018-05-02	Nabriva Therapeutics plcStock OptionA Award	Director	AAward	+29K sh	—	—	29,000
2017-09-27	Nabriva Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+1,350 sh	—	—	33,140
2017-09-27	Nabriva Therapeutics plcStock OptionM Exercise/Conversion	Director	MExercise/Conversion	−1,350 sh	—	—	0
2017-09-15	Nabriva Therapeutics plcStock OptionA Award	Director	AAward	+10.1K sh	—	—	10,100
2017-06-23	Nabriva Therapeutics Legacy plcJ Other	Director	JOther	+31.8K sh	—	—	31,790
2017-06-23	Nabriva Therapeutics Legacy plcStock OptionJ Other	Director	JOther	+40K sh	—	—	40,000
2017-06-23	Nabriva Therapeutics Legacy plcStock OptionJ Other	Director	JOther	+10.1K sh	—	—	10,100
2017-06-19	Nabriva Therapeutics plcS Sale	Director	SSale	−46 sh	$91.00	−$4,186	3,179
2017-06-16	Nabriva Therapeutics plcS Sale	Director	SSale	−24 sh	$93.50	−$2,244	3,225
2017-06-15	Nabriva Therapeutics plcS Sale	Director	SSale	−100 sh	$94.10	−$9,410	3,249
2017-05-30	Nabriva Therapeutics plcS Sale	Director	SSale	−110 sh	$101.50	−$11.2K	3,449
2017-05-30	Nabriva Therapeutics plcS Sale	Director	SSale	−100 sh	$101.00	−$10.1K	3,349
2017-05-25	Nabriva Therapeutics plcS Sale	Director	SSale	−205 sh	$100.50	−$20.6K	3,649
2017-05-25	Nabriva Therapeutics plcS Sale	Director	SSale	−90 sh	$101.00	−$9,090	3,559
2017-05-23	Nabriva Therapeutics plcS Sale	Director	SSale	−30 sh	$99.70	−$2,991	3,854
2017-05-16	Nabriva Therapeutics plcS Sale	Director	SSale	−50 sh	$102.27	−$5,113.4	3,984
2017-05-16	Nabriva Therapeutics plcS Sale	Director	SSale	−100 sh	$103.00	−$10.3K	3,884
2017-05-15	Nabriva Therapeutics plcS Sale	Director	SSale	−50 sh	$101.50	−$5,075	4,034
2017-02-16	Nabriva Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+502 sh	—	—	3,351
2017-02-16	Nabriva Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+155 sh	—	—	3,506
2017-02-16	Nabriva Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+578 sh	—	—	4,084
2017-02-16	Nabriva Therapeutics plcStock OptionM Exercise/Conversion	Director	MExercise/Conversion	−502 sh	—	—	0
2017-02-16	Nabriva Therapeutics plcStock OptionM Exercise/Conversion	Director	MExercise/Conversion	−155 sh	—	—	0
2017-02-16	Nabriva Therapeutics plcStock OptionM Exercise/Conversion	Director	MExercise/Conversion	−578 sh	—	—	135

Recent filings

Accepted (ET)
Jul 314
Talbot George Harrison0001104659-20-089140
SEC(opens sec.gov)
Aug 14
Talbot George Harrison0001104659-19-043344
SEC(opens sec.gov)
Aug 24
Talbot George Harrison0001104659-18-049251
SEC(opens sec.gov)
May 44
Talbot George Harrison0001104659-18-030625
SEC(opens sec.gov)
Sep 294
Talbot George Harrison0001104659-17-060014
SEC(opens sec.gov)
Sep 194
Talbot George Harrison0001104659-17-057953
SEC(opens sec.gov)
Jun 274
Nabriva Therapeutics Plc0001104659-17-041901
SEC(opens sec.gov)
Jun 194
Nabriva Therapeutics AG0001104659-17-040238
SEC(opens sec.gov)
Jun 14
Nabriva Therapeutics AG0001104659-17-037045
SEC(opens sec.gov)
May 254
Nabriva Therapeutics AG0001104659-17-035349
SEC(opens sec.gov)
May 174
Nabriva Therapeutics AG0001104659-17-033537
SEC(opens sec.gov)

Companies

Address

C/O DURATA THERAPEUTICS, INC. 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR

MORRISTOWN, NJ, 07960